Ulipristal acetate

CAS: 126784-99-4

Ref. TM-T2527

Produktinformation

• Name: Ulipristal acetate
• Synonyme: Ulipristal, CDB-2914, (11Beta,17Alpha)-17-Acetyl-11-[4-(Dimethylamino)Phenyl]-3-Oxoestra-4,9-Dien-17-Yl Acetate, (11β)-17-(Acetyloxy)-11-[4-(dimethylamino)phenyl]-19-norpregna-4,9-diene-3,20-dione, 17-Acetoxy-11β-[(4-(N,N-dimethylamino)phenyl]-19-norpregna-4,9-diene-3,20-dione, 17-Acetoxy-11β-[(4-(dimethylamino)phenyl]-19-norpregna-4,9-diene-3,20-dione, 17-Acetyloxy-11β-[(4-(N,N-dimethylamino)phenyl]-19-norpregna-4,9-diene-3,20-dione, 17α-Acetoxy-11β-(4-dimethylaminophenyl)-19-norpregna-4,9-dien-3,20-dione, 17α-Acetoxy-11β-[4-N,N-dimethylaminophenyl]-19-norpregna-4,9-diene-3,20-dione, 19-Norpregna-4,9-diene-3,20-dione, 17-(acetyloxy)-11-[4-(dimethylamino)phenyl]-, (11β)-, Cbd(Va) 2914, Cdb-2914, EllaOne, Esmya, Hrp 2000, Rti-3021-012, Ru 44675, Ulipristal Acetate, Ulipristal,Ella, Va 2914
• CAS: 126784-99-4

Beschreibung

Ulipristal acetate (CDB-2914) is an orally bioavailable, acetate salt of ulipristal, a selective progesterone receptor modulator with anti-progesterone activity. Ulipristal binds to the progesterone receptor (PR), thereby inhibiting PR-mediated gene expression, and interfering with progesterone activity in the reproductive system. As a result, this agent may suppress the growth of uterine leiomyomatosis. Furthermore, by inhibiting or delaying ovulation and effecting endometrial tissue, ulipristal can be used as an emergency contraception.

• Marke: Targetmol

Chemische Eigenschaften

• Molekulargewicht: 475.62
• Formel: C₃₀H₃₇NO₄
• Reinheit: 99.94%
• Farbe/Form: Solid